small molecule drug development for cardiovascular and inflammatory dieseases

History:

Encysive Pharmaceuticals changed their name from Texas Biotechnology in 2003. They were acquired by Pfizer in 2008.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Texas

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: